{
    "clinical_study": {
        "@rank": "23563", 
        "arm_group": {
            "arm_group_label": "All patients", 
            "arm_group_type": "Other", 
            "description": "All patients who get enrolled in the study"
        }, 
        "brief_summary": {
            "textblock": "To provide medical follow-up to patients exposed to BGG492 for more than 28 days in study\n      CBGG492A2207 and/or CBGG492A2212."
        }, 
        "brief_title": "Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Adrenocortical Adenoma", 
            "Sarcoma, Endometrial Stromal"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Adenoma", 
                "Sarcoma, Endometrial Stromal", 
                "Adrenocortical Adenoma", 
                "Sarcoma"
            ]
        }, 
        "detailed_description": {
            "textblock": "The purpose of the study is to provide medical follow-up to patients exposed to BGG492 for\n      more than 28 days in study CBGG492A2207 and/or CBGG492A2212.  Data from study CBGG492A2216\n      will be used to support the clinical safety assessment of BGG492 regarding the observance of\n      uterine endometrial stromal tumors and adrenal cortical adenomas at least one year after the\n      completion of BGG492 treatment."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Total exposure to BGG492 treatment in study CBGG492A2207 and/or CBGG492A2212 must\n             have been greater than 28 days.\n\n          -  At least one year must have elapsed since the patient received his or her last dose\n             of BGG492.\n\n        Exclusion Criteria:\n\n        - None\n\n        Other protocol-defined inclusion criteria may apply."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "77", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 15, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02150213", 
            "org_study_id": "CBGG492A2216", 
            "secondary_id": "2013-003431-29"
        }, 
        "intervention": [
            {
                "arm_group_label": "All patients", 
                "description": "MRI of the abdomen", 
                "intervention_name": "MRI", 
                "intervention_type": "Procedure", 
                "other_name": "Magnetic Resonance Imaging"
            }, 
            {
                "arm_group_label": "All patients", 
                "description": "Dexamethasone Supression test", 
                "intervention_name": "Dexamethasone Supression Test", 
                "intervention_type": "Procedure", 
                "other_name": "Dexamethasone Supression test"
            }, 
            {
                "arm_group_label": "All patients", 
                "description": "Sonogram of the uterus (females only)", 
                "intervention_name": "Sonogram", 
                "intervention_type": "Procedure", 
                "other_name": "Sonogram"
            }, 
            {
                "arm_group_label": "All patients", 
                "description": "Uterine endometrial biopsy (females only)", 
                "intervention_name": "Biopsy", 
                "intervention_type": "Procedure", 
                "other_name": "Uterine biopsy"
            }, 
            {
                "arm_group_label": "All patients", 
                "description": "No study-drug gets administered in this study", 
                "intervention_name": "BGG492", 
                "intervention_type": "Drug", 
                "other_name": "Selurampanel"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Dexamethasone acetate", 
                "Dexamethasone", 
                "Dexamethasone 21-phosphate", 
                "BB 1101"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 28, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Monroe Township", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "08831"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75230"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bernau", 
                        "country": "Germany", 
                        "zip": "16321"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bonn", 
                        "country": "Germany", 
                        "zip": "53105"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kehl-Kork", 
                        "country": "Germany", 
                        "zip": "77694"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ulm", 
                        "country": "Germany", 
                        "zip": "89081"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Firenze", 
                        "country": "Italy", 
                        "state": "FI", 
                        "zip": "50143"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "state": "MI", 
                        "zip": "20142"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hlohovec", 
                        "country": "Slovakia", 
                        "state": "Slovak Republic", 
                        "zip": "92001"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kosice", 
                        "country": "Slovakia", 
                        "state": "Slovak Republic", 
                        "zip": "041 90"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Banska Bystrica", 
                        "country": "Slovakia", 
                        "zip": "97517"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Germany", 
                "Italy", 
                "Slovakia"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "A Multicenter Medical Safety Follow-up Study for Patients With Partial Onset Seizures Who Received More Than 28 Days of Total Exposure to BGG492 in Studies CBGG492A2207 and/or CBGG492A2212", 
        "overall_contact": {
            "last_name": "Novartis Pharmaceuticals", 
            "phone": "1-888-669-6682"
        }, 
        "overall_contact_backup": {
            "last_name": "Novartis Pharmaceuticals", 
            "phone_ext": "+41613241111"
        }, 
        "overall_official": {
            "affiliation": "Novartis Pharmaceuticals", 
            "last_name": "Novartis Pharmaceuticals", 
            "role": "Study Director"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "Germany: Federal Institute for Drugs and Medical Devices (BfArM)", 
                "South Korea: Korea Food and Drug Administration (KFDA)", 
                "Slovakia: State Institute for Drug Control", 
                "Italy: Ministry of Health", 
                "Hungary: National Institute of Pharmacy", 
                "Poland: Ministry of Health"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Incidence of adrenal cortical adenomas as assessed by non-contrast MRI of the abdomen (males and females)", 
                "measure": "Incidence of adrenal cortical adenomas", 
                "safety_issue": "Yes", 
                "time_frame": "By approx day 7 or earlier"
            }, 
            {
                "description": "Incidence of uterine endometrial stromal sarcomas as assessed by sonogram/biopsy (females)", 
                "measure": "Incidence of uterine endometrial stromal sarcomas", 
                "safety_issue": "Yes", 
                "time_frame": "By approx day 31 or earlier"
            }, 
            {
                "description": "Incidence and severity of adverse events", 
                "measure": "Incidence and severity of adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "Monitored for the duration of the study which is approx 42 days"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02150213"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Novartis", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novartis Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}